BOLTON SECURITIES CORPORATION’s AbbVie ABBV Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$4.15M	Buy	+19,799	New	+$3.85M	0.24%	109

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BOLTON SECURITIES CORPORATION's ABBV Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in AbbVie (ABBV) in Q1 2025: 19,799 shares worth $4.15M. The stake represents 0.24% of the portfolio and ranks #109 among its holdings.

3,835 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

BOLTON SECURITIES CORPORATION held 19,799 shares of AbbVie worth $4.15M as of Q1 2025.
AbbVie was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
AbbVie made up 0.24% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #109 holding.
3,835 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.